title: Usefulness of dialysate fibrin degradation products and lactic dehydrogenase isoenzyme patterns in assessing the clinical course of peritonitis.
abstract: OBJECTIVE
  To establish the usefulness of fibrin degradation products (FDP) and lactic dehydrogenase isoenzyme patterns (LDH isoenzyme) in assessing the clinical course of peritonitis.
  
  
  METHODS
  A retrospective study of patients with peritonitis who were divided into three groups according to their clinical course.
  
  
  METHODS
  Single dialysis unit of a general hospital.
  
  
  METHODS
  Patients were treated by intraperitoneal and oral antibiotics.
  
  
  METHODS
  Twenty-six patients with 34 episodes of peritonitis were studied. Group 1 consisted of 21 patients with 26 recoveries from peritonitis; Group 2 consisted of 5 patients with 5 relapsing episodes of peritonitis, and Group 3 consisted of 3 patients with 3 persistent episodes of peritonitis.
  
  
  METHODS
  Concentrations of WBCs, FDP, LDH isoenzyme and microbiological culture of the dialysate were determined.
  
  
  RESULTS
  In most of Group 1, WBCs, FDP, and LDH isoenzyme returned to normal within 2 weeks. In 4 patients of Group 1, who had complications (diverticulitis, cholecystitis, cystitis, and tunnel infection), WBCs, FDP, and LDH isoenzyme returned to normal gradually within 3 weeks. In Group 2, WBCs returned to normal, but FDP remained relatively high and LDH isoenzyme did not normalize. In Group 3, WBCs, FDP and LDH isoenzyme did not normalize.
  
  
  CONCLUSIONS
  Failure of normalization of FDP and LDH isoenzyme suggests an incomplete recovery from peritonitis. FDP and LDH isoenzyme are useful in assessing the course of peritonitis.
authors.affiliation: Division of Nephrology, Sendai Shakaihoken Hospital, Miyagi, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Suzuki
authors.forename: M
authors.initials: M
authors.lastname: Ishizaki
authors.forename: O
authors.initials: O
authors.lastname: Hotta
authors.forename: I
authors.initials: I
authors.lastname: Horigome
authors.forename: K
authors.initials: K
authors.lastname: Sudo
authors.forename: K
authors.initials: K
authors.lastname: Kurosawa
authors.forename: Y
authors.initials: Y
authors.lastname: Taguma
mesh_terms: D015415:Biomarkers / Q000032:analysis; D015314:Dialysis Solutions / Q000737:chemistry; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis*; D006801:Humans; D007527:Isoenzymes; D007770:L-Lactate Dehydrogenase / Q000032:analysis*; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000175:diagnosis* / Q000209:etiology; D012189:Retrospective Studies
chemical_list: D015415:Biomarkers; D015314:Dialysis Solutions; D005338:Fibrin Fibrinogen Degradation Products; D007527:Isoenzymes; D007770:L-Lactate Dehydrogenase